During the past decade, Bajcsy-Zsilinszky Korhaz es Rendelointezet conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 13 clinical trials were completed, i.e. on average, 72.2% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 8 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bajcsy-Zsilinszky Korhaz es Rendelointezet" #1 sponsor was "Ferring Pharmaceuticals" with 2 trials, followed by "Kodiak Sciences Inc" with 2 trials sponsored, "Merck Sharp & Dohme LLC" with 2 trials sponsored, "Amgen" with 1 trials sponsored and "ChemoCentryx" with 1 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bajcsy-Zsilinszky Korhaz es Rendelointezet" #1 collaborator was "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator, "ICON plc" with 1 trials as a collaborator, "Medidata Solutions" with 1 trials as a collaborator, "PPD" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Bajcsy-Zsilinszky Korhaz es Rendelointezet" are "Atrial Fibrillation" (2 trials), "Prostate Cancer" (2 trials), "Urinary Bladder Cancer, Muscle-invasive" (2 trials), "Acute Pain" (1 trials) and "Acute Unilateral Vestibulopathy (AUV)" (1 trials). Many other conditions were trialed in "Bajcsy-Zsilinszky Korhaz es Rendelointezet" in a lesser frequency.

Most popular intervention types in "Bajcsy-Zsilinszky Korhaz es Rendelointezet" are "Drug" (22 trials), "Biological" (4 trials), "Other" (2 trials), "Procedure" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Aflibercept" (2 trials), "Cisplatin" (2 trials), "Degarelix" (2 trials) and "Edoxaban" (2 trials). Other intervention names were less common.

The vast majority of trials in "Bajcsy-Zsilinszky Korhaz es Rendelointezet" are 19 trials for "All" genders, 5 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Bajcsy-Zsilinszky Korhaz es Rendelointezet". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Bajcsy-Zsilinszky Korhaz es Rendelointezet, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Bajcsy-Zsilinszky Korhaz es Rendelointezet, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".